NCT04799392View on ClinicalTrials.gov

NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons

NATerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

October 28, 2021

Study Completion Date

October 28, 2021

Conditions
COVID-19SARS-CoV-2Coronavirus
Interventions
DEVICE

NOWDx COVID-19 Test

The investigational device is the NOWDx COVID-19 Test.

Trial Locations (5)

23230

Bremo Pharmacy, Richmond

55303

Goodrich Pharmacy, Anoka

65714

Alps Specialty Pharmacy, Nixa

65803

Alps Pharmacy, Springfield

72701

Medical Arts Pharmacy, Fayetteville

Sponsors
All Listed Sponsors
lead

NOWDiagnostics, Inc.

INDUSTRY

NCT04799392 - NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons | Biotech Hunter | Biotech Hunter